Linezolid Sandoz (Linezolid)

Linezolid is indicated for infections caused by susceptible Gram‑positive bacteria.

• Complicated skin and soft‑tissue infections: achieves bacterial eradication and clinical cure.
• Community‑acquired bacterial pneumonia: provides effective treatment of Gram‑positive pathogens.
• Ventilator‑associated bacterial pneumonia: clears infection caused by resistant Gram‑positive organisms.

• Linezolid binds to the 50S ribosomal subunit of susceptible bacteria, preventing the formation of the initiation complex required for protein synthesis. This inhibition halts bacterial growth, acting bacteriostatically against most organisms and bactericidally at higher concentrations, thereby reducing the bacterial load in infected tissues.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: watery stools, often self‑limiting.
• Headache: transient cranial discomfort.
• Metallic taste: altered taste sensation.
• Vomiting: occasional emesis.
• Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects

• Thrombocytopenia: significant drop in platelet count requiring monitoring.
• Peripheral neuropathy: numbness or tingling in extremities.
• Optic neuritis: visual disturbances, potentially irreversible.
• Serotonin syndrome: risk when combined with serotonergic agents.
• Lactic acidosis: metabolic disturbance with high morbidity.
• Myelosuppression: bone‑marrow suppression leading to anemia or leukopenia.

When prescribing Linezolid, clinicians should consider several safety aspects.

• Renal impairment: monitor renal function and adjust therapy as needed.
• Hepatic impairment: assess liver enzymes regularly.
• Serotonergic agents: avoid concomitant use to prevent serotonin syndrome.
• Myelosuppression: perform baseline and periodic complete blood counts.
• Hypersensitivity: discontinue immediately if rash or anaphylaxis occurs.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

• SSRIs, SNRIs, and other serotonergic drugs: increased risk of serotonin syndrome.
• Monoamine oxidase inhibitors (MAOIs): may cause severe hypertension.
• Rifampicin: markedly reduces linezolid plasma concentrations.

Moderate Interactions (Monitor Closely)

• Warfarin: may potentiate anticoagulant effect, requiring INR monitoring.
• Erythromycin: can raise linezolid levels, increasing toxicity risk.
• Anticonvulsants (e.g., carbamazepine): may lower linezolid efficacy, necessitating clinical observation.